Remeron
Back to Test Catalogue
Mirtazapine (Remeron), Serum/Plasma
Test ID: FMIRT
Test
Aliases/Synonyms
Method
High Performance Liquid Chromatography with Fluorescence Detection (HPLC-FL)
Report Includes
Mirtazapine
Specimens
Avoid gel separator tubes Serum (Preferred); Plasma (Acceptable)
Test Location
MN, USA
Test Version
23-Mar-2023
Specimen
Specimens
Avoid gel separator tubes Serum (Preferred); Plasma (Acceptable)
Collection Containers
Preferred
Red top (no additive)
Acceptable
Green top (Sodium heparin)
Sample Volume
2 mL
Minimum Volume
0.3 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | 72 hours |
|---|---|
| Refrigerated | 14 days |
| Frozen | 180 days |
Rejection Criteria
| Specimen | Gel-separator tubes |
|---|
Test Version
23-Mar-2023
Performance / Interpretation
Method
High Performance Liquid Chromatography with Fluorescence Detection (HPLC-FL)
Turnaround Time
11 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Mirtazapine | ng/mL |
|
||
|
Expected steady state trough mirtazapine concentrations in patients receiving recommended daily dosages: 4.0-40.0 ng/mL
Toxic range not established Test performed at: Medtox Laboratories Inc., 402 W. County Road D, St. Paul, MN 55112 |
||||
Test Location
MN, USA
Test Version
23-Mar-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| FMIRT | 64814Mirtazapine | ng/mL |
Test Version
23-Mar-2023